Position in SGMOQ
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$261,308
-$158,814 QoQ
Shares Held
1,045,232
+4.5% QoQ
Ownership
0.252%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in SGMOQ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $261,308 | 1,045,232 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $420,122 | 1,000,292 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $541,849 | 808,731 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $367,444 | 680,452 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $319,370 | 483,894 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $269,933 | 264,641 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $259,411 | 298,174 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $113,227 | 314,521 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $192,971 | 288,019 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $87,627 | 162,274 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $110,927 | 184,879 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $233,066 | 179,282 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $294,765 | 167,481 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $442,970 | 141,074 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $659,979 | 134,690 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $573,260 | 138,469 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $744,765 | 128,187 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $647,219 | 86,296 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $840,712 | 93,309 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,598,418 | 801,873 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $9,491,010 | 757,463 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,027,527 | 706,440 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $5,865,199 | 620,656 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $521,310 | 58,182 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $408,731 | 64,165 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||